Potomac Capital Management, Inc. Enzo Biochem Inc Transaction History
Potomac Capital Management, Inc.
- $56.8 Million
- Q4 2023
A detailed history of Potomac Capital Management, Inc. transactions in Enzo Biochem Inc stock. As of the latest transaction made, Potomac Capital Management, Inc. holds 1,481,742 shares of ENZ stock, worth $1.1 Million. This represents 3.63% of its overall portfolio holdings.
Number of Shares
1,481,742
Previous 1,455,000
1.84%
Holding current value
$1.1 Million
Previous $2.04 Million
1.13%
% of portfolio
3.63%
Previous 2.75%
Shares
8 transactions
Others Institutions Holding ENZ
# of Institutions
48Shares Held
15.5MCall Options Held
2.3KPut Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$3.83 Million3.43% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.53MShares$1.87 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$1.39 Million0.0% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$987,5149.62% of portfolio
-
Black Rock Inc. New York, NY955KShares$706,7170.0% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $36.1M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...